financetom
Business
financetom
/
Business
/
Update: XPeng Shares Rise After Q1 Non-GAAP Loss Narrows, Revenue Increases
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Update: XPeng Shares Rise After Q1 Non-GAAP Loss Narrows, Revenue Increases
May 21, 2024 7:32 AM

10:14 AM EDT, 05/21/2024 (MT Newswires) -- (Updates with the latest stock price movement in the headline and first paragraph.)

XPeng ( XPEV ) shares were up nearly 13% in recent Tuesday trading after the company's Q1 non-GAAP loss narrowed year-over-year while revenue rose.

The company reported a Q1 non-GAAP net loss of 1.49 Chinese renminbi ($0.21) per diluted American depositary share, narrowing from the non-GAAP net loss of 2.57 renminbi per ADS a year earlier.

Three analysts polled by Capital IQ expected a non-GAAP net loss of 1.77 renminbi per ADS.

Revenue for the quarter ended March 31 was 6.55 billion renminbi, up from 4.03 billion renminbi a year earlier.

Four analysts polled by Capital IQ expected 6.41 billion renminbi.

The company said it expects Q2 revenue of 7.5 billion renminbi to 8.3 billion renminbi. Analysts polled by Capital IQ expect 10.65 billion renminbi.

Price: 9.35, Change: +1.07, Percent Change: +12.91

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Brazil's Natura &Co in talks with IG4 for potential Avon deal
Brazil's Natura &Co in talks with IG4 for potential Avon deal
Feb 20, 2025
SAO PAULO (Reuters) - Brazilian cosmetics maker Natura &Co said on Thursday that it is in exclusive talks with asset manager IG4 for the potential sale of Avon's operations outside Latin America, but noted the negotiations were still at an early stage. The company continues to evaluate other strategic alternatives, it said in a securities filing. Natura in December said...
Leonardo DRS' Q4 Adjusted Earnings, Revenue Rise; Sets 2025 Guidance
Leonardo DRS' Q4 Adjusted Earnings, Revenue Rise; Sets 2025 Guidance
Feb 20, 2025
07:57 AM EST, 02/20/2025 (MT Newswires) -- Leonardo DRS ( DRS ) reported Q4 adjusted earnings Thursday of $0.38 per diluted share, up from $0.31 a year earlier. Analysts polled by FactSet expected $0.35. Revenue for the quarter ended Dec. 31 was $981 million, up from $926 million a year earlier. Three analysts surveyed by FactSet expected $942.2 million. The...
BridgeBio Pharma Q4 Loss Widens, Revenue Rises -- Shares Up Pre-Bell
BridgeBio Pharma Q4 Loss Widens, Revenue Rises -- Shares Up Pre-Bell
Feb 20, 2025
07:58 AM EST, 02/20/2025 (MT Newswires) -- BridgeBio Pharma ( BBIO ) reported a Q4 net loss Thursday of $1.40 per diluted share, compared with a loss of $0.96 a year earlier. Analysts polled by FactSet expected a loss of $1.13. Revenue for the quarter ended Dec. 31 was $5.9 million, up from $1.74 million a year earlier. Analysts surveyed...
Supremex Q4 Adjusted Profit Rises
Supremex Q4 Adjusted Profit Rises
Feb 20, 2025
07:57 AM EST, 02/20/2025 (MT Newswires) -- Supremex ( SUMXF ) on Thursday reported higher fourth-quarter adjusted profit. Adjusted net earnings were $5.2 million or $0.20 per share for the three-month period ended December 31, compared with $2.2 million or $0.09 per share for the equivalent period in 2023. Total revenue fell 4.5% to $69.1 million, with decreases in both...
Copyright 2023-2026 - www.financetom.com All Rights Reserved